RNA footprinting and modification interference analysis.
Clarke
P A
PA
Cancer Research Campaign (CRC) Centre for Cancer Therapeutics, Royal Marsden Hospital, Surrey, United Kingdom.
D000814:Aniline Compounds / Q000737:chemistry; D004047:Diethyl Pyrocarbonate / Q000737:chemistry; D005038:Ethylnitrosourea / Q000737:chemistry; D006834:Hydrazines / Q000494:pharmacology; D017665:Hydroxyl Radical / Q000737:chemistry; D009691:Nucleic Acid Denaturation; D012313:RNA / Q000032:analysis*; D016601:RNA-Binding Proteins / Q000737:chemistry; D012260:Ribonucleases / Q000378:metabolism; D012261:Ribonucleoproteins / Q000737:chemistry*; D017421:Sequence Analysis; D013463:Sulfuric Acid Esters / Q000737:chemistry
D000814:Aniline Compounds; D006834:Hydrazines; D016601:RNA-Binding Proteins; D012261:Ribonucleoproteins; D013463:Sulfuric Acid Esters; C029424:hydrazine; D017665:Hydroxyl Radical; D012313:RNA; D012260:Ribonucleases; C007482:dimethyl sulfate; D004047:Diethyl Pyrocarbonate; D005038:Ethylnitrosourea; C023650:aniline